Bank of America’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$152 Buy
136
+25
+23% +$28 ﹤0.01% 6850
2025
Q1
$140 Buy
111
+5
+5% +$6 ﹤0.01% 6708
2024
Q4
$241 Sell
106
-1
-0.9% -$2 ﹤0.01% 6627
2024
Q3
$370 Buy
107
+8
+8% +$28 ﹤0.01% 6507
2024
Q2
$504 Buy
99
+32
+48% +$163 ﹤0.01% 6465
2024
Q1
$564 Sell
67
-3
-4% -$25 ﹤0.01% 6363
2023
Q4
$287 Buy
70
+3
+4% +$12 ﹤0.01% 6361
2023
Q3
$200 Sell
67
-278
-81% -$830 ﹤0.01% 6476
2023
Q2
$10.7K Buy
345
+22
+7% +$680 ﹤0.01% 5963
2023
Q1
$16K Sell
323
-66
-17% -$3.27K ﹤0.01% 5999
2022
Q4
$9.56K Buy
389
+29
+8% +$713 ﹤0.01% 6115
2022
Q3
$23K Sell
360
-147
-29% -$9.39K ﹤0.01% 6110
2022
Q2
$21K Buy
507
+26
+5% +$1.08K ﹤0.01% 6353
2022
Q1
$24K Buy
481
+275
+133% +$13.7K ﹤0.01% 6643
2021
Q4
$12K Sell
206
-576
-74% -$33.6K ﹤0.01% 6779
2021
Q3
$38K Sell
782
-1,639
-68% -$79.6K ﹤0.01% 6266
2021
Q2
$138K Sell
2,421
-764
-24% -$43.5K ﹤0.01% 5543
2021
Q1
$184K Buy
3,185
+60
+2% +$3.47K ﹤0.01% 5435
2020
Q4
$213K Buy
3,125
+549
+21% +$37.4K ﹤0.01% 4844
2020
Q3
$654K Sell
2,576
-1,692
-40% -$430K ﹤0.01% 3970
2020
Q2
$718K Buy
4,268
+1,137
+36% +$191K ﹤0.01% 3890
2020
Q1
$219K Buy
3,131
+1,598
+104% +$112K ﹤0.01% 4475
2019
Q4
$98K Buy
1,533
+133
+10% +$8.5K ﹤0.01% 5191
2019
Q3
$82K Hold
1,400
﹤0.01% 5313
2019
Q2
$83K Hold
1,400
﹤0.01% 5318
2019
Q1
$91K Buy
1,400
+67
+5% +$4.36K ﹤0.01% 5178
2018
Q4
$71K Hold
1,333
﹤0.01% 5325
2018
Q3
$76K Hold
1,333
﹤0.01% 5281
2018
Q2
$78K Buy
1,333
+333
+33% +$19.5K ﹤0.01% 5191
2018
Q1
$47K Hold
1,000
﹤0.01% 5325
2017
Q4
$59K Sell
1,000
-4
-0.4% -$236 ﹤0.01% 5199
2017
Q3
$62K Buy
1,004
+4
+0.4% +$247 ﹤0.01% 5063
2017
Q2
$62K Hold
1,000
﹤0.01% 5039
2017
Q1
$64K Hold
1,000
﹤0.01% 5079
2016
Q4
$38K Buy
1,000
+320
+47% +$12.2K ﹤0.01% 5272
2016
Q3
$24K Buy
680
+10
+1% +$353 ﹤0.01% 5281
2016
Q2
$24K Buy
+670
New +$24K ﹤0.01% 5350
2014
Q4
Sell
-2,889
Closed -$178K 5928
2014
Q3
$178K Buy
+2,889
New +$178K ﹤0.01% 4134